Transactions, M&A, Finance Raise
Ofichem
- Acquisition of Innogenerics, a drug product fill and finish (FDF) manufacturing business in Leiden, Netherlands
ExcellGene
- Development of growth strategy, business plan preparation support, indicative valuation, selection, and approach of potential investors and collaboration partners
Novartis
- Divestment of API manufacturing facility in Mahad, India to Olon
- Divestment of manufacturing site for sterile drug product fill & finish (FDF) located in Basel, Switzerland to Lonza
GHO Capital
- Acquisition of Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) based in the Netherlands
- Acquisition of UK based Fine Organics from North Edge Capital
Boehringer Ingelheim
- Acquisition of biopharmaceutical manufacturing site in Fremont, USA from Amgen
- Divestment of Resomer® a resorbable polymer platform for drug delivery and medical device applications to Evonik Industries
- Strategic licensing collaboration and equity investment with Ablynx to discover, develop and commercialize novel nanobody therapeutics
Merz Pharma
- Acquisition of Biotech Therapeutics developing botulinum neurotoxins for medical use
InstrAction
- Joint venture with biotech company Puls in biomolecule purification
Strategy, Due Diligence, Business Development
Ofichem
- Development of strategic plan, comprehensive and aligned documentation covering business and functional strategies that are updated on an annual basis
- Development of M&A strategy and identification of potential acquisition opportunities
- Commercial due diligence support with add-on acquisitions
Celonic
- Strategic support for m-RNA vaccine manufacturing ramp-up
Currax Pharmaceuticals
- Business plan, investor presentation, approach of outside US licensing partners
Green Energy Materials
- Development of market entry strategy for lithium-ion battery separator manufacturing in Europe
- Collaboration with technology partner HCNMT
- Approach of financial and strategic investors
- Development and implementation of strategic planning process
Boehringer Ingelheim
- Market mapping and identification of potential acquisition opportunities in immunotherapy and monoclonal antibodies
Heraeus
- Identification of business potential and value creation opportunities in highly active pharmaceutical ingredients "hAPIs"
- Identification of value creation opportunities for API manufacturing, catalysis and precious metal recycling